 The COVID-19 pandemic caused by SARS-CoV-2 has created global chaos, leading to a state of medical emergency and prompting countries to allocate resources towards developing immunotherapeutics and immunomodulators for prophylaxis and treatment. This article was authored by ModicBalutu, Zenat Hamid, is our rather and others.